Form EFFECT Turn Therapeutics Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 2, 2026 |
| Accession Number: | 0001213900-26-037583 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Turn Therapeutics expands GX-03 atopic dermatitis trial scope
- eGhanaVisa.com Launches a Secure Digital Visa Assistance Platform, Introducing USDT Cryptocurrency Payments for Travelers Applying to Visit Ghana
- Ares Management Corporation Updates the Time of Its Earnings Conference Call for the Second Quarter Ending June 30, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
